|
Volumn 25, Issue 5, 2007, Pages 485-486
|
Critics pan timid European response to TeGenero disaster
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
MONOCLONAL ANTIBODY;
TGN 1412;
UNCLASSIFIED DRUG;
CLINICAL TRIAL;
CYTOKINE RELEASE;
DISABILITY;
DRUG EFFECT;
DRUG INDUSTRY;
DRUG RESEARCH;
DRUG SAFETY;
EUROPE;
FOOD AND DRUG ADMINISTRATION;
HEALTH SERVICE;
HUMAN;
IMMUNE RESPONSE;
IMMUNOTHERAPY;
NOTE;
PRIORITY JOURNAL;
SIDE EFFECT;
ANTIBODIES, MONOCLONAL;
CLINICAL TRIALS;
EUROPEAN UNION;
GOVERNMENT REGULATION;
HUMAN EXPERIMENTATION;
HUMANS;
|
EID: 34249720078
PISSN: 10870156
EISSN: 15461696
Source Type: Journal
DOI: 10.1038/nbt0507-485 Document Type: Note |
Times cited : (7)
|
References (0)
|